Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Postoperative Delirium in Orthopedic Surgery
NCT05236907Completed
- Sponsor
- University of Baghdad
- Start
- Jul 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of melatonin in postoperative delirium (POD) (3 arms), sponsored by University of Baghdad. Primary endpoint: The efficacy of oral Melatonin in preventing Postoperative Delirium after general anesthesia at 1 week. Started Jul 2020; status: completed.
02
Drugs
melatonin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05236907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05236907.